In the last trading session, 23.59 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.69. With the company’s per share
Plus Therapeutics Inc (NASDAQ:PSTV) has a beta value of 0.63 and has seen 19.84 million shares traded in the last trading session. The company, currently
During the last session, Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares were 23.26 million, with the beta value of the company hitting 0.62. At the end
Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares stood at 2.48 million during the last session, with the company’s beta value hitting 0.64. At the close of
In the last trading session, 2.71 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.61. With the company’s per share
Plus Therapeutics Inc (NASDAQ:PSTV) has a beta value of 0.60 and has seen 11.73 million shares traded in the last trading session. The company, currently
During the last session, Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares were 2.17 million, with the beta value of the company hitting 0.66. At the end
In the last trading session, 1.31 million shares of the Plus Therapeutics Inc (NASDAQ:PSTV) were traded, and its beta was 0.71. Most recently the company’s
Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares stood at 5.51 million during the last session, with the company’s beta value hitting 0.63. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne